Convalescence after arthroscopic capsular release in frozen shoulder

Sedlinsch, Alexej; Berndt, Thomas; Rühmann, O.; Lerch, Solveig

doi:10.1016/j.jor.2020.06.013

Cited by 4 publications

(5 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding ROM in this study, all significantly improved from preoperative time to last follow as follow: internal rotation mean increased from 0.67° to 39.6°, external rotation at 0 abduction mean increased from 2.3°to 69.8°, external rotation with abduction mean increased from1.67° to 74.17°, abduction mean increased from 42.5° to 155.6°, forward flexion mean increased from 78.6° to 166.6° and extension mean increased from 13.5° to 41.5° at last follow up. Our results are coincident with other studies (26,27,28,29) . There was a significant difference between diabetic and non-diabetic patients in postoperative forward flexion, postoperative external rotation at 0° abduction, postoperative external rotation with abduction and postoperative internal rotation where the non-diabetic group showed a better improvement in range of motion (18) .…”

Section: Discussionsupporting

confidence: 93%

“…Shoulder range of motion and clinical outcomes improved significantly compared with preoperative level according to Constant, Oxford scores that were used for assessment; 93% of cases obtained an excellent or good result at an average one year of follow-up. Our overall results of arthroscopic capsular release at mean 12 months of follow-up are favorable and comparable to those former reports (26,27,28,29) .…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Outcome After Arthroscopic Capsular Release for Refractory Idiopathic Frozen Shoulder between Diabetic and Non-Diabetic Patients

deriny¹,

El-Ganainy²,

Ahmed³

et al. 2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: This study evaluated the clinical outcome of the arthroscopic capsular release for refractory idiopathic frozen shoulder between diabetic and non-diabetic patients. Patients and Methods: Between August 2020 and April 2022 a prospective study investigated thirty shoulders in 30 patients who had refractory primary frozen and undergone arthroscopic arthrolysis. Assessment was fulfilled using the Constant's shoulder score, Oxford shoulder score, visual analogue scale (VAS) for pain and measuring ranges of motion (ROM) at preoperative, six months postoperatively and at the final follow-up. Results: There were 17 females and 13 males with a mean age of 47.8 (SD 7.5) years. The right shoulder was affected in ten patients and the other 20 had left frozen shoulder. Before surgery, the average time of frozen shoulder was 12.53 (SD 4.2) months. Diabetic patients constituted 56.6%, and mean follow-up was 12.33 (SD 2.9) months. Arthroscopy revealed subacromial adhesions in 73.3% and partial rotator cuff tears in 23%. The Constant's score, Oxford shoulder score, VAS for pain and ROM in all directions significantly increased at the final follow-up, compared to preoperative levels. There were statistically significant differences between diabetic and non-diabetic patients regarding postoperative flexion ROM, postoperative external rotation at 0° abduction, postoperative external rotation with abduction and postoperative internal rotation where non-diabetics showed better ROM and significant improvement in postoperative Constant shoulder score. The mean course of disease after surgery was 3.1 (SD 1.2) and complications represented 6.6%. Conclusions: Arthroscopic release for refractory idiopathic frozen shoulder is an effective procedure. Better results are encountered in non-diabetic patients than diabetic counterparts.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussionsupporting

confidence: 91%

Outcome After Arthroscopic Capsular Release for Refractory Idiopathic Frozen Shoulder between Diabetic and Non-Diabetic Patients

deriny¹,

El-Ganainy²,

Ahmed³

et al. 2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

“…At present, arthroscopic capsular release is gradually popularized and applied in the treatment of frozen shoulder. Studies have shown that application of arthroscopic capsular release has good safety and efficacy, and can remove the proliferative synovium, adhesive fibrous tissues and damaged tissues in the shoulder joint, and repair damaged tissues ( 18 , 19 ). The main reasons for pain and limited ROM caused by frozen shoulder are local inflammation and soft tissue adhesion.…”

Section: Discussionmentioning

confidence: 99%

Clinical efficacy of intra-articular infusion of cocktail combined with tranexamic acid in the treatment of middle-age and older patients with frozen shoulder following arthroscopic capsular release

et al. 2023

View full text Add to dashboard Cite

ObjectiveTo investigate the clinical efficacy of arthroscopic capsular release and postoperative intra-articular infusion of cocktail combined with tranexamic acid (TXA) in the treatment of patients with frozen shoulder.MethodA total of 85 middle-aged and older patients with frozen shoulder who underwent arthroscopic capsular release and received intra-articular infusion of TXA alone (n = 28), cocktail alone (n = 26), and cocktail plus TXA (n = 31) after surgery were retrospective analyzed. The drainage volume within 24 h after surgery, postoperative length of hospital stay, postoperative complications, visual analog scale (VAS), Neer shoulder assessment scale, ASES score, and range of motion (ROM) of the shoulder joint at 1 day, 1 week, 1 month, and 3 months after surgery in all three groups were recorded and compared.ResultsPostoperative length of hospital stay was significantly shorter in the cocktail + TXA and cocktail groups than that in the TXA group. Postoperative drainage volume was significantly higher in the cocktail group compared with TXA + cocktail group (P < 0.05). At 1 day and 1 week after surgery, pain was more pronounced in the TXA group, which was significantly relieved in the cocktail and the cocktail + TXA groups (P < 0.05). Pain was significantly relieved in all the three groups at 1 and 3 months after surgery. Significant functional improvement of the shoulder was achieved in all three groups at 1 week after surgery, the improvement was apparent in the cocktail + TXA groups (P < 0.05), followed by the cocktail group. At 1 month after surgery, patients in the cocktail + TXA groups obtained excellent functional recovery of the shoulder joint. At 3 months after surgery, patients in all the three groups both obtained good recovery of the shoulder joint function, and the recovery was apparent in the cocktail + TXA groups (P < 0.05).ConclusionArthroscopic capsular release and postoperative intra-articular infusion of cocktail combined with TXA has good safety and efficacy in the treatment of middle-age and older patients with frozen shoulder, which can reduce postoperative pain and intra-articular bleeding, promote early postoperative functional exercises and accelerate early postoperative recovery.

show abstract

“…In another study of 127 patients with frozen shoulders, grouped by symptom duration (onset to surgical intervention), arthroscopic release brought effective and rapid improvement in shoulder motion and function, unrelated to surgical timing [ 29 ]. The duration of frozen shoulder was apparently shortened by arthroscopic capsular release [ 29 , 30 ], reducing the natural disease course by > 12 months [ 30 ]. In the present study, passive ROM in group A improved enough to finished most of the daily work at Week 4, and enabling near-normal ROM and shoulder function by postoperative Week 12, the course of frozen shoulder was shortened as a result.…”

Section: Discussionmentioning

confidence: 99%

Combined arthroscopic release with corticosteroid hydrodilatation versus corticosteroid hydrodilatation only in treating freezing-phase primary frozen shoulder: a randomized clinical trial

Dai

Liu

et al. 2022

BMC Musculoskelet Disord

View full text Add to dashboard Cite

Background There has been no ideal treatment for freezing-phase frozen shoulder to rapidly relieve pain and improve joint mobility. No any other team directly compared the effectiveness of combination of arthroscopic release and corticosteroid hydrodilatation with corticosteroid hydrodilatation only in treatment of freezing-phase frozen shoulder. Methods Seventy-two patients with freezing-phase frozen shoulder were randomly assigned to combined arthroscopic release with corticosteroid hydrodilatation (group A) or corticosteroid hydrodilatation only (group B). Clinical states were examined at baseline and periodically (Weeks 1, 4, 12, 24 and 1 year) after intervention by passive ROM; visual analog scale (VAS); UCLA and Disabilities of the Arm, Shoulder, and Hand (DASH) score. Results The passive ROM, VAS, UCLA and DASH scores always improved along the time points (all p < 0.01). The passive abduction (pAB), passive forward flexion (pFL), passive external rotation (pER), passive internal rotation (pIR) were better in group A than in group B at Week 1, 4, 12, 24 (all p < 0.01). At 1 year post-operation, the pFL and pIR were better in group A than in group B (all p < 0.01). VAS scores of group A were similar with those of group B (all p > 0.01), the differences between group A and group B were all lower than minimal clinically important difference (MCID). At Week 12, the UCLA sores and DASH scores were 26.8 ± 3.8, 14.2 ± 2.0 in group A versus 22.3 ± 3.4, 22.5 ± 3.1 in group B (all p < 0.01). At Week 24 post-operation, there were 32.7 ± 2.0, 9.8 ± 1.5 in group A versus 26.3 ± 3.6, 17.5 ± 3.5 in group B (all p < 0.01). At 1 year post-operation, there were 34.5 ± 0.8, 1.7 ± 1.5 in group A versus 32.1 ± 2.3, 8.8 ± 2.8 in group B (all p < 0.01), the differences of UCLA scores between group A and group B at Week 24 was higher than the MCID. There were no complications such as infection, nerve or vascular injury. Conclusions Combined arthroscopic release with corticosteroid hydrodilatation would yield better results in passive ROM and function than corticosteroid hydrodilatation only. Trial registration ChiCTR1900024235, July 2, 2019 (Retrospectively registered).

show abstract

Convalescence after arthroscopic capsular release in frozen shoulder

Cited by 4 publications

References 24 publications

Outcome After Arthroscopic Capsular Release for Refractory Idiopathic Frozen Shoulder between Diabetic and Non-Diabetic Patients

Outcome After Arthroscopic Capsular Release for Refractory Idiopathic Frozen Shoulder between Diabetic and Non-Diabetic Patients

Clinical efficacy of intra-articular infusion of cocktail combined with tranexamic acid in the treatment of middle-age and older patients with frozen shoulder following arthroscopic capsular release

Combined arthroscopic release with corticosteroid hydrodilatation versus corticosteroid hydrodilatation only in treating freezing-phase primary frozen shoulder: a randomized clinical trial

Contact Info

Product

Resources

About